Chiba, Japan

Chika Miyoshi

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Kracie Pharma, Ltd., National Cancer Center, The University of Toyama. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chika Miyoshi. Retrieved from https://idiyas.com/inventor/chika-miyoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Chiba, JP (2015 - 2017)
  • Kashiwa, JP (2017)

Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chika Miyoshi: Pioneering Innovations in Anti-Cancer Research

Introduction

Chika Miyoshi, a prominent inventor based in Chiba, Japan, has made significant contributions to the field of cancer treatment through her innovative research. With a total of three patents to her name, Miyoshi's work focuses primarily on the development of effective anti-cancer agents, harnessing the properties of natural extracts.

Latest Patents

Miyoshi's latest patent involves a novel anti-cancer agent aimed at providing a treatment for patients suffering from pancreatic cancer. This inventive solution is based on administering a formulated agent containing burdock fruit extract with a daily dosage of arctigenin of 100 mg or more. The efficacy of this agent has been demonstrated through observed tumor-reducing effects and confirmed lowering of tumor markers in patients. Furthermore, her invention also includes an anticancer agent that combines arctigenin and arctiin in a specific weight ratio of 0.7 to 1.3, enhancing its therapeutic potential.

Another critical patent by Miyoshi focuses on the production of a burdock fruit extract with a high content of arctigenin, specifically designed for the treatment of pancreatic cancer. This extract is produced by enzymatically converting arctiin into arctigenin using beta-glucosidase, an enzyme naturally occurring in burdock fruit, followed by a meticulous extraction and concentration process.

Career Highlights

Throughout her career, Chika Miyoshi has collaborated with esteemed institutions, including the University of Toyama and Kracie Pharma, Ltd. Her tenure at these organizations showcases her commitment to advancing cancer research and developing innovative treatment solutions.

Collaborations

Miyoshi has worked alongside notable colleagues such as Toshiki Okubo and Satoshi Yomoda, contributing to a collaborative environment that fosters groundbreaking advancements in anti-cancer technologies. Their combined efforts have paved the way for significant developments in the field.

Conclusion

Chika Miyoshi is an inspiring figure in the world of innovation and cancer research. Her inventions and patents not only reflect her dedication to improving patient outcomes but also highlight the potential of natural extracts in medical applications. With ongoing research and innovative solutions, Miyoshi continues to make strides in the fight against cancer, showcasing the impact of dedicated inventors in scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…